Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          T-705, also known as favipiravir, is a small-molecule inhibitor that is currently in clinical development for the treatment of influenza virus infections. This molecule also inhibits the replication of a broad spectrum of other RNA viruses. The objective of this study was to investigate the antiviral effect of favipiravir on chikungunya virus (CHIKV) replication and to contribute to unravelling the molecular mechanism of action against this virus.

          Related collections

          Author and article information

          Journal
          J. Antimicrob. Chemother.
          The Journal of antimicrobial chemotherapy
          1460-2091
          0305-7453
          Oct 2014
          : 69
          : 10
          Affiliations
          [1 ] Laboratory for Virology and Experimental Chemotherapy, Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, 3000 Leuven, Belgium.
          [2 ] Laboratory for Virology and Experimental Chemotherapy, Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, 3000 Leuven, Belgium Laboratorio de Entomología Médica, Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Calle 63D 24-31, Bogotá DC, Colombia.
          [3 ] Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
          [4 ] UMR_D 190 "Emergence des Pathologies Virales" (Aix-Marseille University, IRD French Institute of Research for Development, EHESP French School of Public Health), Marseille, France.
          [5 ] Laboratory for Medicinal Chemistry, Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, 3000 Leuven, Belgium.
          [6 ] Laboratorio de Entomología Médica, Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Calle 63D 24-31, Bogotá DC, Colombia.
          [7 ] Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
          [8 ] Laboratory for Virology and Experimental Chemotherapy, Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, 3000 Leuven, Belgium johan.neyts@rega.kuleuven.be.
          Article
          dku209
          10.1093/jac/dku209
          24951535
          c35ecafe-7d5d-429b-9fa0-f4241abc67d6
          © The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
          History

          alphavirus,nsP4,polymerase
          alphavirus, nsP4, polymerase

          Comments

          Comment on this article